First reported case of Rothia dentocariosa spondylodiscitis in an immunocompetent patient. (2020)

• Record Type: Journal Article
• Authors: Schwob, Jean-Marc; Porto, Violène; Aebischer Perone, Sigiriya; Van Delden, Christian; Eperon, Gilles; Calmy, Alexandra
• Is Part Of: IDCases. Volume 19(2019)
• Publication Date: 2020
• Subjects: Rothia dentocariosa -- Spondylodiscitis -- Bacteremia -- Osteomyelitis; Communicable diseases -- Periodicals; Communicable Diseases -- Case Reports; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1016/j.idcr.2019.e00689
• Languages: English
• ISSNs: 2214-2509

Abstract

Highlights: Rothia dentocariosa is part of the normal oropharynx microflora in 1.3%–29% of healthy individuals. R. dentocariosa rarely causes a severe systemic condition. The spread of R. dentocariosa beyond the oropharynx must be identified and rapidly treated with antimicrobials. There is limited data available on R. dentocariosa antimicrobial susceptibilities. The ceftriaxone-rifampin combination is a good option. Abstract: Rothia dentocariosa is part of the normal human oropharyngeal microflora and is frequently associated with dental caries and periodontal disease. Invasive disease has been described essentially in immunocompromised hosts and/or patients with underlying conditions as predisposing factors. We present a case of an otherwise healthy 46-years old male with spondylodiscitis caused by this pathogen. Treatment with ceftriaxone and rifampin was successful. To our knowledge, this is the first R. dentocariosa spondylodiscitis reported in an immunocompetent patient, and the second one in the literature overall.